Skip to main content
. 2023 May 2;10(5):ofad231. doi: 10.1093/ofid/ofad231

Table 2.

Adverse Events (N = 300)

Adverse Event No. (%)
Eye related 11 (3.7)
 Blurred vision 8 (2.7)
 Red eye 2 (0.66)
 Eye pain 2 (0.66)
 Watery eye 1 (0.33)
Gastrointestinal related 84 (28)
 Nausea/vomiting 66 (22)
 Loose stool 13 (4.3)
 Abdominal discomfort 13 (4.3)
 Loss of appetite 6 (2)
Other 26 (8.7)
 Body pain 10 (3.3)
 Weakness 7 (2.3)
 Giddiness 4 (1.3)
 Headache 3 (1)
 Abnormal behavior 2 (0.66)
 Burning sensation of body 2 (0.66)